logo
welcome
Investor's Business Daily

Investor's Business Daily

Neumora Therapeutics stock crashes 83.2% after depression treatment fails

Investor's Business Daily
Summary
Nutrition label

74% Informative

Neumora Therapeutics stock crashed 83.2% to 1.78% in premarket trading.

The company's drug showed no difference from a placebo in treating depression symptoms.

The results were "very surprising given the prior data from them and JNJ ," RBC Capital Markets analyst Brian Abrahams said.

VR Score

76

Informative language

82

Neutral language

19

Article tone

formal

Language

English

Language complexity

48

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

detected

Known propaganda techniques

not detected

Time-value

short-lived

Affiliate links

no affiliate links